comparemela.com
Home
Live Updates
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis? : comparemela.com
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis.
Related Keywords
California ,
United States ,
Cincinnati ,
Ohio ,
Stanford University ,
Stockholm ,
Sweden ,
Solna ,
Stanford ,
University Of Cincinnati ,
Peter Stenvinkel ,
Glenn Chertow ,
Silvi Shah ,
Division Of Nephrology ,
Division Of Renal Medicine At Karolinska Institutet ,
Stanford University School Of Medicine ,
European Renal Association Congress ,
European Renal Association ,
Stanford University School ,
Albumin Improvements Called ,
Renal Medicine ,
Karolinska Institutet ,
Medscape Medical ,
United States Renal Data System ,
comparemela.com © 2020. All Rights Reserved.